JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 39 No. 1 119-124
© 1998 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dams, E. T.M.
Right arrow Articles by Corstens, F. H.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dams, E. T.M.
Right arrow Articles by Corstens, F. H.M.

Technetium-99m Labeled to Human Immunoglobulin G Through the Nicotinyl Hydrazine Derivative: A Clinical Study

Els T.M. Dams, Wim J.G. Oyen, Otto C. Boerman, Roel A.M.J. Claessens, Ate B. Wymenga, Jos W.M. van der Meer and Frans H.M. Corstens

Departments of Nuclear Medicine and Internal Medicine, University Hospital Nijmegen, and Department of Orthopedics, St. Maartenskliniek, Nijmegen, The Netherlands

Correspondence: For correspondence or reprints contact: E.Th., M. Dams, MD, Department of Internal Medicine, University Hospital, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.

ABSTRACT

A novel method to label polyclonal human immunoglobulin G (IgG) with 99mTc through the nicotinyl hydrazine derivative (HYNIC) has shown promising results in the detection of experimental infection. In this study, 99mTc-labeled HYNIC-IgG was directly compared to 111In-labeled diethylenetriaminepentaacetic acid (DTPA)-IgG in patients suspected of infectious or inflammatory disease. Methods: Thirty-seven patients (22 women and 15 men; mean age = 54 yr, range = 17–78 yr) with 39 suspected infectious or inflammatory foci were prospectively studied. After administration of 740 MBq 99mTc-HYNIC-IgG, imaging was performed at 4 and 24 hr postinjection. To avoid cross-over activity, 111In-DTPA-IgG was injected 24 hr after 99mTc-HYNIC-IgG and imaged at 4, 24 and 48 hr postinjection. The scintigraphic results were confirmed by microbiological, histological, radiological and clinical methods. Results: Technetium-99m-HYNIC-IgG and 111In-DTPA-IgG scintigraphy showed 100% concordancy. All 17 patients with proven infection or inflammation (19 foci, mainly localized in the locomotor system) had positive scintigraphic findings. No false-negative scintigrams were recorded. In three patients, the scintigrams were concordantly false-positive. As a result, the sensitivity and specificity of imaging infectious or inflammatory foci with 99mTc-HYNIC-IgG and 111In-DTPA-IgG in these patients were 100% and 85%, respectively. Conclusion: Technetium-99m-HYNIC-IgG scintigraphy is equally as effective as 111In-IgG scintigraphy for the detection of infection and inflammation. The apparent physical and logistic advantages of 99mTc over 111In make 99mTc-HYNIC-IgG a promising new radiopharmaceutical for imaging infection and inflammation.

Key Words: infection • inflammation • immunoglobulin G • HYNIC • imaging




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
P Barrera, W J G Oyen, O C Boerman, and P L C M van Riel
Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis
Ann Rheum Dis, September 1, 2003; 62(9): 825 - 828.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Goel, J. Baranowska-Kortylewicz, S. H. Hinrichs, J. Wisecarver, G. Pavlinkova, S. Augustine, D. Colcher, B. J.M. Booth, and S. K. Batra
99mTc-Labeled Divalent and Tetravalent CC49 Single-Chain Fv's: Novel Imaging Agents for Rapid In Vivo Localization of Human Colon Carcinoma
J. Nucl. Med., October 1, 2001; 42(10): 1519 - 1527.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1998 by the Society of Nuclear Medicine.